Breast cancer is the leading cause of cancer deaths in women today. According to the World Health Organization (WHO), one in every 12 women have the risk of a breast abnormality. Early diagnosis is very critical to decrease mortality rates. We, at NIRAMAI, have developed a novel software-based medical device to detect breast cancer at a much earlier stage than traditional methods or self-examination. Our solution is a low cost, accurate, automated, portable cancer screening tool that can be operated in any clinic. Our imaging method is radiation free, non-touch, not painful and works for women of all ages. The core technology of our solution has been developed using our patented machine learning algorithms for reliable and accurate detection of breast cancer. This unique solution can be used as a cancer diagnosis test in hospitals, for regular preventive health checkups, and also for large scale screening in rural and semi-urban areas.
Radiation-free. Does not require any incision.
No one touches or even sees you
Best in class sensitivity & specificity.
NIRAMAI stands for "Non-Invasive Risk Assessment with Machine Intelligence"
Breast Cancer is the leading type of cancer in women. According to WHO, one in every 8 women in US is at the risk of developing a breast abnormality in her life time. It is well-established that…
Read More
The core of NIRAMAI solution is Thermalytix, a computer aided diagnostic engine that is powered by Artificial Intelligence. The solution uses a high resolution thermal sensing device and a cloud hosted analytics solution for analysing the thermal…
Read More
NIRAMAI Thermalytix has been validated in systematic clinical studies in reputed hospitals.
Read MoreMore than 800+ articles about Niramai Health Analytix
US markets now open for the Innovative Indian Startup Bengaluru,…
Niramai among winners of The Global Women’s HealthTech Awards announced…
Bengaluru-based healthtech startup Niramai Health Analytix’s patented, radiation-free breast cancer…
Niramai has great opportunities to improve women’s lives and health around the world, using technology and AI.
Thermography can detect breast cancer in ways that are non-invasive, non-ionizing and non-traumatizing. In addition to detecting tumor growth earlier, this innovation can bring breast cancer screening to the doorsteps of women all over the world. I am happy to partner with Niramai on this journey.
I congratulate Team Niramai for developing an innovative thermal analytics based Breast Cancer Solution for early stage breast cancer detection. This Non-Invasive Risk Assessment with Machine Intelligence, cancer screening solution is relevant for women of all ages and poses minimal health hazard since it is contact and radiation free. I believe Niramai will enable easy adoption for early cancer screening and will play a key role in improving outcomes in our ongoing battle against breast cancer. I am delighted to support this initiative.
Selected for Marico Innovation Foundation Scale-Up program and tagged as Pride of India
Niramai was awarded Aegis Graham Bell Award 2018 under Innovative Mobile App for Consumer
Niramai is among 4 startups from India that got selected for Google Launchpad Accelerator Program 2018
